A New Solution for Delicate and Precise Middle Ear Surgery: Delivering Optimal Laser Performance with OtoLase™
September 16 2016 - 10:15AM
Lumenis Ltd., the world’s largest energy-based medical device
company for surgical, aesthetic and ophthalmic applications,
announces the introduction of OtoLase™, the new otology designated
enhancement for the AcuPulse™ family of products. Specifically
designed for enhanced precision and ease of use in middle ear
surgery, the innovative OtoLase will be showcased at the American
Academy of Otolaryngology – Head and Neck Surgery Foundation
(AAO-HNSF) Annual meeting 2016, being held in San Diego on
September 18-21, 2016.
Photos accompanying this release are available
at http://www.globenewswire.com/NewsRoom/AttachmentNg/beee4af5-1eff-4d63-9b66-d01e88977f71 and http://www.globenewswire.com/NewsRoom/AttachmentNg/47010816-251b-4988-9289-b180a74dc97d.
The OtoLase solution, compatible with the AcuPulse DUO laser
system, is a combination of reusable fiber and handpieces with
different single-use tips, allowing for smooth, individualized and
cost effective operation of varied pathologies in the middle ear.
Based on clinical studies, otologic procedures with CO2 laser
technology have shown superior outcomes compared with other
modalities.1,2,3 With the ergonomic and operational design of
OtoLase, surgeons are equipped with great precision and excellent
visualization allowing them to remove layer-by-layer undesired
tissue and enhance clinical outcomes of delicate ear
procedures.
“OtoLase has been engineered for safety and ease of use. The air
flow system eliminates the laser plume and facilitates
visualization, and the aiming beam ensures target accuracy,” said
John T. McElveen Jr., M.D. from Carolina Ear & Hearing Clinic
in Raleigh, North Carolina. “The low profile and thin design allows
the surgeon to reach the smallest recesses within the middle ear.
This enhanced fiberoptic CO2 laser technology has been
worth the wait.”
The versatile AcuPulse DUO laser system with OtoLase and the
wide range of designated accessories, is an upgradable,
all-inclusive solution for a range of diverse ear surgery
treatments, including otosclerosis, cholesteatoma, tympanoplasty,
myringotomy/tympanostomy, scar tissue dissection, acoustic neuroma
and more. The laser system can be used for office and
hospital-based procedures.
“With a 50-year history of redefining medical treatments and
providing gold standard clinical advances, Lumenis has
revolutionized the approach to micro laser surgery with its
energy-based technology,” said Tzipi Ozer-Armon, CEO of Lumenis.
“By striving to provide innovative tools to improve surgical
performance, Lumenis continues to deliver next-generation
energy-based solutions for our partners in the medical community
and enhance patient care.”
AAO-HNSF conference attendees are invited to Lumenis booth #1635
to hear experts talk about their experience with the new OtoLase
solution:
September 18-19 at 9:30 AM PT: Dr. Seilesh C. Babu September
18-20 at 10 AM PT: Dr. John T. McElveen
In addition, Dr. Paul F. Castellanos will present his operating
experience with the UltraPulse® DUO – the most advanced laser
console in otolaryngology. His talk "The UltraPulse DUO CO2 Laser
Fiber and the Difficult Airway" will take place on September 18 at
10:30 AM PT and September 19 at 1:30 PM PT.
Personal hands-on sessions on the Lumenis DUO platforms will be
available all through the exhibiting hours at Lumenis booth. For
more information about Lumenis, please visit: www.Lumenis.com.
About Lumenis Lumenis is a global leader in the
field of minimally-invasive clinical solutions for the Surgical,
Ophthalmology and Aesthetic markets, and is a world-renowned expert
in developing and commercializing innovative energy-based
technologies, including Laser, Intense Pulsed Light (IPL),
Radio-Frequency (RF) and ultrasound. For nearly 50 years, Lumenis'
ground-breaking products have redefined medical treatments and have
set numerous technological and clinical gold-standards. Lumenis has
successfully created solutions for previously untreatable
conditions, as well as designed advanced technologies that have
revolutionized existing treatment methods. For more information
visit: www.lumenis.com
References:
1. Marchese, M.R., et al., "One-shot" CO2 versus Er:YAG laser
stapedotomy: is the outcome the same? Eur Arch Otorhinolaryngol,
2011. 268(3): p. 351-6.
2. Lesinski SG, Lasers for otosclerosis--which one if any and
why, Lasers Surg Med. 1990;10(5):448-57.
3. Motta, G. and L. Moscillo, Functional results in stapedotomy
with and without CO2 laser. ORL J Otorhinolaryngol Relat Spec,
2002. 64(5): p. 307-10.
For further information:
Glenn Silver
Lazar Partners Ltd.
(646) 871-8495
LUMENIS LTD (NASDAQ:LMNS)
Historical Stock Chart
From May 2024 to Jun 2024
LUMENIS LTD (NASDAQ:LMNS)
Historical Stock Chart
From Jun 2023 to Jun 2024